In silico identification of novel allosteric inhibitors of Dengue virus NS2B/NS3 serine protease

12Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Although dengue is a disease that affects more than 100 countries and puts almost 400 million lives at risk each year, there is no approved antiviral in the treatment of this pathology. In this context, proteases are potential biological targets since they are essential in the replication process of this virus. In this study, a library of more than 3,000 structures was used to explore the allosteric inhibition of the NS2B/NS3 protease complex using consensual docking techniques. The results show four best ranked structures that were selected for molecular dynamics and free energy simulations. The present analysis corroborates with other studies (experimental and theoretical) presented in the literature. Thus, the computational approach used here proved to be useful for planning new inhibitors in the combat against Dengue disease.

Cite

CITATION STYLE

APA

Costa, R. A. D. A., da Rocha, J. A. P., Pinheiro, A. S., da Costa, A. S. S., da Rocha, E. C. M., Josino, L. P. C., … Brasil, D. S. B. (2022). In silico identification of novel allosteric inhibitors of Dengue virus NS2B/NS3 serine protease. Journal of the Serbian Chemical Society, 87(6), 693–706. https://doi.org/10.2298/JSC210929011D

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free